Company / Interest Expense
Avidity Biosciences, Inc. Interest Expense History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
-
FY2022
5-year range
$0 / $0
FY2018-FY2022
Trend
-
vs FY2021
Sector context
#40 of 44
Health Care
What the data says
Improved from $209,000 to $0 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 44
▼
Key checks
Key Insights
- Peak interest expense was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0 | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $209.0K | -97.2% |
| FY2019 | $7.4M | +928.8% |
| FY2018 | $718.0K | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026